Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: Regional heterogeneity and postmortem artifacts

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 5, 1999, Pages 685-690

  Okuhata, Yoshitaka ^a,b   Brasch, Robert C ^a   Pham, Christine D ^a   Daldrup, Heike ^a   Wendland, Michael F ^a   Shames, David M ^a   Roberts, Timothy P L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood volume; Cancer; Macromolecular; Microvascularity control media; MRI

Indexed keywords

ALBUMIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ANIMAL MODEL; ARTICLE; ARTIFACT; BLOOD VOLUME; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; INTRAVENOUS DRUG ADMINISTRATION; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0032901225     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1522-2586(199905)9:5<685::aid-jmri10>3.0.co;2-%23     Document Type: Article

References (33)

1. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-3051.
2. Jain R. Barriers to drug delivery in solid tumors. Sci Am 1994;271: 58-65.
3. Chalkley HW. Method for the quantitative morphologic analysis of tissues. J Natl Cancer Inst 1943;4:47-53.
4. Weibel ER. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 1963;12:131-155.
5. Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res 1971;31:587-589.
6. Warren BA. The vascular morphology of tumors. In: Petersen HI, editor. Tumor blood circulation. Boca Raton, FL: CRC Press: 1979. p 1-47.
7. Hilmas DE, Gillette EL. Morphometric analyses of the microvasculature of tumors during growth and after X-irradiation. Cancer 1974;33:103-110.
8. Mountcastle V. Medical physiology, 13th ed. St. Louis: CV Mosby; 1974. p 1019-1026.
9. Grunt TW, Lametschwandtner A, Staindl O. The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts. Microvasc Res 1985;29: 371-386.
10. Kuwatsuru R, Shames DM, Muhler A, et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993;30:76-81.
11. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993;29:616-622.
12. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818.
13. Pham C, Roberts T, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 1998;6:224-230.
14. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Am J Roentgenol 1995;164:1147-1152.
15. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207: 529-538.
16. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
17. Hilf R, Freeman J, Michel I, Borman A. Characterization of a transplantable lactating mammary tumor. Cancer Res 1964;24:812-822.
18. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998;28:67-78.
19. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization [published erratum appears in Invest Radiol 1988;23:961]. Invest Radiol 1987;22:665-671.
20. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987;162: 205-210.
21. Wikstrom MG, Moseley ME, White DL, et al. Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989;24:609-615.
22. White D, Wang S-C, Aicher K, Dupon J, Engelstad B, Brasch R. Albumin-(DTPA-Gd) 15-20: whole body clearance, and organ distribution of gadolinium. In: Society of Magnetic Resonance in Medicine 8th Annual Meeting, Amsterdam, 1989. p 807.
23. Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short T1 inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34:845-852.
24. Fassel VA. Simultaneous or sequential determination of the elements at all concentration levels: the renaissance of an old approach. Anal Chem 1979;51 (suppl A): 1290A-1308A.
25. Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990;9:253-266.
26. Young JS, Lumsden CE, Stalker AL. The significance of the "tissue pressure" of normal testicular and neoplastic (Brown-Pearce carcinoma) tissue in the rabbit. J Pathol Bacteriol 1950;62:313-333.
27. Nugent LJ, Jain RK. Pore and fiber-matrix models for diffusive transport in normal and neoplastic tissues. Microvasc Res 1984;28: 270-274.
28. Jarden JO. Pathophysiological aspects of malignant brain tumors studied with positron emission tomography. Acta Neurol Scand Suppl 1994;156:1-35.
29. Meyer KL, Joseph PM, Mukherji B, Livolsi VA, Lin R. Measurement of vascular volume in experimental rat tumors by 19F magnetic resonance imaging. Invest Radiol 1993;28:710-719.
30. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90.
31. Bradley WG Jr. Waluch V. Blood flow: magnetic resonance imaging. Radiology 1985;154:443-450.
32. Donahue K, Weisskoff R, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
33. Roberts T, Roberts H, Brasch R. Optimizing imaging techniques to reduce errors in microvascular quantification with macromolecular MR contrast agents. Acad Radiol 1998;5:5113-5116.